Obesity, Type II diabetes and the Ala54Thr polymorphism of fatty acid binding protein 2 in the Tongan population

Molecular Genetics and Metabolism

Volumn 79, Issue 3, 2003, Pages 183-188

  Duarte, Natalia L ^a   Colagiuri, Stephen ^a   Palu, Taniela ^b   Wang, Xing Li ^a,c   Wilcken, David E L ^a  

^a PRINCE OF WALES HOSPITAL   (Australia)

^b Vaiola Hospital   (Tonga)

^c Vaiola Hospital ^*  (United States)

Author keywords

BMI; Cholesterol; FABP2 Ala54Thr polymorphism; Obesity; Polynesia; Population study; Tonga; Type II diabetes

Indexed keywords

ALANINE; CHOLESTEROL; FATTY ACID BINDING PROTEIN; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LIPID; LOW DENSITY LIPOPROTEIN CHOLESTEROL; THREONINE;

ADOLESCENT; ADULT; AGED; ALLELE; ARTICLE; BODY MASS; CANADA; CAUCASIAN; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; ETHNOLOGY; EUROPE; FEMALE; FINLAND; GENE FREQUENCY; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENETIC VARIABILITY; GENOTYPE; GLUCOSE TOLERANCE; HUMAN; INDIA; JAPAN; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; POPULATION RESEARCH; PREVALENCE; PRIORITY JOURNAL; SWEDEN; TONGA; UNITED STATES;

EID: 0038015588     PISSN: 10967192     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1096-7192(03)00088-X     Document Type: Article

References (29)

1. Colagiuri S., Colagiuri R., Na'ati S., Muimuiheata S., Hussain Z., Palu T. The prevalence of diabetes in the kingdom of Tonga. Diabetes Care. 25:2002;1378-1383.
2. Prochazka M., Lillioja S., Tait J.F., Knowler W.C., Mott D.M., Spraul M., Bennett P.H., Bogardus C. Linkage of chromosomal markers on 4q with a putative gene determining maximal insulin action in Pima Indians. Diabetes. 42:1993;514-519.
3. Lowe J.B., Sacchettini J.C., Laposata M., McQuillan J.J., Gordon J.I. Expression of rat intestinal fatty acid-binding protein in Escherichia coli. Purification and comparison of ligand binding characteristics with that of Escherichia coli-derived rat liver fatty acid-binding protein. J. Biol. Chem. 262:1987;5931-5937.
4. Baier L.J., Sacchettini J.C., Knowler W.C., Eads J., Paolisso G., Tataranni P.A., Mochizuki H., Bennett P.H., Bogardus C., Prochazka M. An amino acid substitution in the human intestinal fatty acid binding protein is associated with increased fatty acid binding, increased fat oxidation, and insulin resistance. J. Clin. Invest. 95:1995;1281-1287.
5. Baier L.J., Bogardus C., Sacchettini J.C. A polymorphism in the human intestinal fatty acid binding protein alters fatty acid transport across Caco-2 cells. J. Biol. Chem. 271:1996;10892-10896.
6. Levy E., Menard D., Delvin E., Stan S., Mitchell G., Lambert M., Ziv E., Feoli-Fonseca J.C., Seidman E. The polymorphism at codon 54 of the FABP2 gene increases fat absorption in human intestinal explants. J. Biol. Chem. 276:2001;39679-39684.
7. Yamada K., Yuan X., Ishiyama S., Koyama K., Ichikawa F., Koyanagi A., Koyama W., Nonaka K. Association between Ala54Thr substitution of the fatty acid-binding protein 2 gene with insulin resistance and intra-abdominal fat thickness in Japanese men. Diabetologia. 40:1997;706-710.
8. Pihlajamaki J., Rissanen J., Heikkinen S., Karjalainen L., Laakso M. Codon 54 polymorphism of the human intestinal fatty acid binding protein 2 gene is associated with dyslipidemias but not with insulin resistance in patients with familial combined hyperlipidemia. Arterioscler. Thromb. Vasc. Biol. 17:1997;1039-1044.
9. Boullu-Sanchis S., Lepretre F., Hedelin G., Donnet J.P., Schaffer P., Froguel P., Pinget M. Type 2 diabetes mellitus: association study of five candidate genes in an Indian population of Guadeloupe, genetic contribution of FABP2 polymorphism. Diabetes Metab. 25:1999;150-156.
10. Hegele R.A., Harris S.B., Hanley A.J., Sadikian S., Connelly P.W., Zinman B. Genetic variation of intestinal fatty acid-binding protein associated with variation in body mass in aboriginal Canadians. J. Clin. Endocrinol. Metab. 81:1996;4334-4337.
11. Vidgren H.M., Sipilainen R.H., Heikkinen S., Laakso M., Uusitupa M.I. Threonine allele in codon 54 of the fatty acid binding protein 2 gene does not modify the fatty acid composition of serum lipids in obese subjects. Eur. J. Clin. Invest. 27:1997;405-408.
12. Sipilainen R., Uusitupa M., Heikkinen S., Rissanen A., Laakso M. Variants in the human intestinal fatty acid binding protein 2 gene in obese subjects. J. Clin. Endocrinol. Metab. 82:1997;2629-2932.
13. Yagi T., Nishi S., Hinata S., Murakami M., Yoshimi T. A population association study of four candidate genes (hexokinase II, glucagon-like peptide-1 receptor, fatty acid binding protein-2, and apolipoprotein Cwith with type 2 diabetes and impaired glucose tolerance in Japanese subjects. Diabetes Med. 13:1996;902-907.
14. Ito K., Nakatani K., Fujii M., Katsuki A., Tsuchihashi K., Murata K., Goto H., Yano Y., Gabazza E.C., Sumida Y., Adachi Y. Codon 54 polymorphism of the fatty acid binding protein gene and insulin resistance in the Japanese population. Diabetes Med. 16:1999;119-124.
15. Hayakawa T., Nagai Y., Nohara E., Yamashita H., Takamura T., Abe T., Nomura G., Kobayashi K. Variation of the fatty acid binding protein 2 gene is not associated with obesity and insulin resistance in Japanese subjects. Metabolism. 48:1999;655-657.
16. Lei H.H., Coresh J., Shuldiner A.R., Boerwinkle E., Brancati F.L. Variants of the insulin receptor substrate-1 and fatty acid binding protein 2 genes and the risk of type 2 diabetes, obesity, and hyperinsulinemia in African-Americans: the Atherosclerosis Risk in Communities Study. Diabetes. 48:1999;1868-1872.
17. Saarinen L., Pulkkinen A., Kareinen A., Heikkinen S., Lehto S., Laakso M. Variants of the fatty acid-binding protein 2 gene are not associated with coronary heart disease in nondiabetic subjects and in patients with NIDDM. Diabetes Care. 21:1998;849-850.
18. Pratley R.E., Baier L., Pan D.A., Salbe A.D., Storlien L., Ravussin E., Bogardus C. Effects of an Ala54Thr polymorphism in the intestinal fatty acid-binding protein on responses to dietary fat in humans. J. Lipid Res. 41:2000;2002-2008.
19. Tahvanainen E., Molin M., Vainio S., Tiret L., Nicaud V., Farinaro E., Masana L., Ehnholm C. Intestinal fatty acid binding protein polymorphism at codon 54 is not associated with postprandial responses to fat and glucose tolerance tests in healthy young Europeans. Results from EARS II participants. Atherosclerosis. 152:2000;317-325.
20. Swinburn B.A., Craig P.L., Daniel R., Dent D.P., Strauss B.J. Body composition differences between Polynesians and Caucasians assessed by bioelectrical impedance. Int. J. Obes. Relat. Metab. Disord. 20:1996;889-894.
21. Mitchell B.D., Kammerer C.M., O'Connell P., Harrison C.R., Manire M., Shipman P., Moyer M.P., Stern M.P., Frazier M.L. Evidence for linkage of postchallenge insulin levels with intestinal fatty acid-binding protein (FABP2) in Mexican-Americans. Diabetes. 44:1995;1046-1053.
22. Chiu K.C., Chuang L.M., Chu A., Yoon C. Fatty acid binding protein 2 and insulin resistance. Eur. J. Clin. Invest. 31:2001;521-527.
23. Chiu K.C., Chuang L.M., Yoon C. The A54T polymorphism at the intestinal fatty acid binding protein 2 is associated with insulin resistance in glucose tolerant Caucasians. BMC Genet. 2:2001;7.
24. Galluzzi J.R., Cupples L.A., Meigs J.B., Wilson P.W., Schaefer E.J., Ordovas J.M. Association of the Ala54-Thr polymorphism in the intestinal fatty acid-binding protein with 2-h postchallenge insulin levels in the Framingham Offspring Study. Diabetes Care. 24:2001;1161-1166.
25. Agren J.J., Vidgren H.M., Valve R.S., Laakso M., Uusitupa M.I. Postprandial responses of individual fatty acids in subjects homozygous for the threonine- or alanine-encoding allele in codon 54 of the intestinal fatty acid binding protein 2 gene. Am. J. Clin. Nutr. 73:2001;31-35.
26. Carlsson M., Orho-Melander M., Hedenbro J., Almgren P., Groop L.C. The T 54 allele of the intestinal fatty acid-binding protein 2 is associated with a parental history of stroke. J. Clin. Endocrinol. Metab. 85:2000;2801-2804.
27. Hegele R.A., Wolever T.M., Story J.A., Connelly P.W., Jenkins D.J. Intestinal fatty acid-binding protein variation associated with variation in the response of plasma lipoproteins to dietary fibre. Eur. J. Clin. Invest. 27:1997;857-862.
28. Hegele R.A., Young T.K., Connelly P.W. Are Canadian Inuit at increased genetic risk for coronary heart disease? J. Mol. Med. 75:1997;364-370.
29. Hegele R.A., Connelly P.W., Hanley A.J., Sun F., Harris S.B., Zinman B. Common genomic variants associated with variation in plasma lipoproteins in young aboriginal Canadians. [published erratum appears in Arterioscler. Thromb. Vasc. Biol. 17 (10) (1997) 2306] Arterioscler. Thromb. Vasc. Biol. 17:1997;1060-1066.